Form 4: Tarsus Pharmaceuticals Director Bhaskar Chaudhuri Reports Stock Transactions

Director Bhaskar Chaudhuri reports the acquisition and disposal of Tarsus Pharmaceuticals common stock related to the settlement of vested Restricted Stock Units (RSUs).

Summary

• On June 24, 2024, Bhaskar Chaudhuri, a director of Tarsus Pharmaceuticals, reported transactions involving the company's common stock.
• These transactions involved the settlement of 3,350 vested Restricted Stock Units (RSUs), resulting in the acquisition of 3,350 shares of common stock.
• Following the reported transactions, Chaudhuri beneficially owns 5,350 shares of Tarsus Pharmaceuticals common stock directly.
• The RSUs were granted on June 22, 2023, and vested on the one-year anniversary, contingent upon continuous service as a non-employee director.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the director's activity in managing their equity stake in the company.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it reflects the director's compensation and equity ownership.

Key Dates